Qube Research & Technologies (QRT)’s Achieve Life Sciences ACHV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,405	Closed	-$66.6K	–	3486
2025 Q4	$66.6K	Sell	13,405 -36,261	-73%	-$158K	﹤0.01%	3252
2025 Q3	$156K	Sell	49,666 -52,915	-52%	-$145K	﹤0.01%	2988
2025 Q2	$232K	Buy	+102,581	New	+$292K	﹤0.01%	2878
2024 Q2	–	Sell	-4,029	Closed	-$18.3K	–	3725
2024 Q1	$18.3K	Buy	4,029 +4,028	+402,800%	+$17.9K	﹤0.01%	3713
2023 Q4	$4	Hold	1	–	–	﹤0.01%	4214
2023 Q3	$4	Buy	+1	New	+$5	﹤0.01%	3973

Other funds holding ACHV

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACHV Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 13,405 shares — an estimated $66.6K sold.

Qube Research & Technologies (QRT) first reported a position in ACHV in Q3 2023 and held it in 6 quarters. The position peaked at $232K in Q2 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Qube Research & Technologies (QRT) reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 13,405 Achieve Life Sciences shares in Q1 2026, an estimated $66.6K.
Qube Research & Technologies (QRT) first reported a position in Achieve Life Sciences in Q3 2023 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Achieve Life Sciences position peaked at $232K in Q2 2025.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.